These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15121766)

  • 1. Cardiovascular genetics: are we there yet?
    Sturm AC
    J Med Genet; 2004 May; 41(5):321-3. PubMed ID: 15121766
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart attack gene discovered; prevention steps remain crucial.
    Heart Advis; 2004 Feb; 7(2):2. PubMed ID: 15106568
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the genetic basis of coronary artery disease.
    Wang Q
    Curr Atheroscler Rep; 2005 May; 7(3):235-41. PubMed ID: 15811259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miscues on the "lack of MEF2A mutations" in coronary artery disease.
    Wang Q; Rao S; Topol EJ
    J Clin Invest; 2005 Jun; 115(6):1399-400; author reply 1400-1. PubMed ID: 15931371
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular genetics of coronary artery disease.
    Wang Q
    Curr Opin Cardiol; 2005 May; 20(3):182-8. PubMed ID: 15861005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery disease and the MEF2A transcription factor.
    Olson EN
    Sci Aging Knowledge Environ; 2003 Dec; 2003(48):pe33. PubMed ID: 14657507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor MEF2A mutations in patients with coronary artery disease.
    Bhagavatula MR; Fan C; Shen GQ; Cassano J; Plow EF; Topol EJ; Wang Q
    Hum Mol Genet; 2004 Dec; 13(24):3181-8. PubMed ID: 15496429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing kit on the horizon for heart disease.
    Heart Advis; 2004 Dec; 7(12):2. PubMed ID: 15782432
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular genomics.
    Sabatine MS; Seidman JG; Seidman CE
    Circulation; 2006 Mar; 113(11):e450-5. PubMed ID: 16549641
    [No Abstract]   [Full Text] [Related]  

  • 10. Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family.
    Maiolino G; Colonna S; Zanchetta M; Pedon L; Seccia TM; Cesari M; Vigili de Kreutzenberg S; Avogaro A; Rossi GP
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):557-60. PubMed ID: 21450604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
    Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
    Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival.
    Heidenreich KA; Linseman DA
    Mol Neurobiol; 2004 Apr; 29(2):155-66. PubMed ID: 15126683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the role of the Myocyte-specific Enhancer Factor-2A gene in coronary artery disease.
    Elhawari S; Al-Boudari O; Muiya P; Khalak H; Andres E; Al-Shahid M; Al-Dosari M; Meyer BF; Al-Mohanna F; Dzimiri N
    Atherosclerosis; 2010 Mar; 209(1):152-4. PubMed ID: 19782985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2A sequence variants and coronary artery disease: a change of heart?
    Altshuler D; Hirschhorn JN
    J Clin Invest; 2005 Apr; 115(4):831-3. PubMed ID: 15841171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development.
    Creemers EE; Sutherland LB; McAnally J; Richardson JA; Olson EN
    Development; 2006 Nov; 133(21):4245-56. PubMed ID: 17021041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocyte enhancer factor 2 and chorion factor 2 collaborate in activation of the myogenic program in Drosophila.
    Tanaka KK; Bryantsev AL; Cripps RM
    Mol Cell Biol; 2008 Mar; 28(5):1616-29. PubMed ID: 18160709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oogenic function of the myogenic factor D-MEF2: negative regulation of the decapentaplegic receptor gene thick veins.
    Mantrova EY; Schulz RA; Hsu T
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11889-94. PubMed ID: 10518546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population.
    Han Y; Yang Y; Zhang X; Yan C; Xi S; Kang J
    Clin Chem Lab Med; 2007; 45(8):987-92. PubMed ID: 17579569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of Common, Complex Coronary Artery Disease.
    Musunuru K; Kathiresan S
    Cell; 2019 Mar; 177(1):132-145. PubMed ID: 30901535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-dependent recruitment of MEF2 proteins to target promoters.
    Morin S; Charron F; Robitaille L; Nemer M
    EMBO J; 2000 May; 19(9):2046-55. PubMed ID: 10790371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.